DURECT Corp (NASDAQ:DRRX)

2.26
Delayed Data
As of Jul 02
 -0.08 / -3.42%
Today’s Change
0.68
Today|||52-Week Range
3.42
+186.37%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$270.2M

Company Description

DURECT Corp. is a specialty pharmaceutical company, which engages in development of pharmaceutical products for pain and chronic diseases based on its proprietary drug delivery technology platforms. It manufactures and sells osmotic pumps used in laboratory research, and designs, develops and manufactures a wide range of biodegradable polymers and excipients for pharmaceutical and medical device clients for use as raw materials in their products. DURECT also conducts research and development of pharmaceutical products in collaboration with third party pharmaceutical and biotechnology companies. The company was founded by James E. Brown and Felix Theeuwe on February 6, 1998 and is headquartered in Cupertino, CA.

Contact Information

DURECT Corp.
10260 Bubb Road
Cupertino California 95014-4166
P:(408) 777-1417
Investor Relations:

Employees

Shareholders

Mutual fund holders9.01%
Other institutional32.48%
Individual stakeholders20.31%

Top Executives

Felix TheeuwesChairman & Chief Scientific Officer
James E. BrownPresident, Chief Executive Officer & Director
Judy JoiceSenior VP-Operations & Corporate Quality Assurance
Matthew J. HoganSecretary, Chief Financial & Accounting Officer
Wei Qi LinVice President-Research & Development

To view my watchlist

Not a member yet?

Sign up now for a free account